MedPath

Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial

Phase 2
Withdrawn
Conditions
Carpal Tunnel Syndrome
Interventions
Procedure: Single-portal Endoscopic Carpal Tunnel Release (Microaire®)
Procedure: Knifelight
Registration Number
NCT01756820
Lead Sponsor
University of Ioannina
Brief Summary

The purpose of this study is to determine whether Single-portal Endoscopic Carpal Tunnel Release (Agee technique, SmartRelease™, MicroAire) and mini-open technique (Knifelight®, Stryker) are equally effective and safe surgical options for the treatment of primary Carpal Tunnel Syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • primary Carpal Tunnel Syndrome

  • no symptoms' relief after 3 months of conservative treatment (NSAIDS, Cast, rest)

    • electrophysiological examination confirms the Carpal Tunnel Syndrome
Exclusion Criteria
  • Secondary Carpal Tunnel Syndrome
  • Pregnancy
  • Rheumatoid diseases
  • Previous trauma at hand or other condition that may effect the anatomy (eg infections)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single-portal Endoscopic Carpal Tunnel Release (Microaire®)Single-portal Endoscopic Carpal Tunnel Release (Microaire®)Single-portal Endoscopic Carpal Tunnel Release (Microaire®) will be used, according to the endoscopic technique described by Agee at al.
Knifelight®KnifelightA mini-open technique will be performed, using the Knifelight® (Stryker).
Primary Outcome Measures
NameTimeMethod
Overall Satisfactionat 1 and 6 months postoperatively

Satisfaction will be assessed by two ways

* by answering to the question "are you happy with the result of the surgery?"

* with a VAS score (0-100) assessing the satisfaction

Complicationsup to 6 months postoperatively

Any complication will be reported including remaining numbness, pain in incision, painful scar, complex regional pain syndrome, infection etc

Secondary Outcome Measures
NameTimeMethod
Painat 1 and 6 months postoperatively

Pain will be assessed

* as a dichotomous outcome (yes/no)

* as a continuous outcome (VAS score)

Grip strengthat 1 and 6 months postoperatively
key pinchat 1 and 6 months postoperatively
Time to return to Activities of Daily Living (ADL) and return to workup to the end of the study

Time to return to Activities of Daily Living (ADL) will be reported. Return to work will also be reported for participants that are employed.

Recurrences and reoperationsup to the end of study
Symptom Severity Scale (SSS)at 1 and 6 months postoperatively
Function Severity Status (FSS)at 1 and 6 months postoperatively

Trial Locations

Locations (1)

University Hospital of Ioannina

🇬🇷

Ioannina, Greece

© Copyright 2025. All Rights Reserved by MedPath